Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 4/2020

01-06-2020 | Myocarditis | IM - CASE RECORD

Why can flu be so deadly? An unusual case of cardiogenic shock

Authors: Michele Ciabatti, Elisa Vignini, Alessio Mattesini, Carlo Di Mario, Serafina Valente

Published in: Internal and Emergency Medicine | Issue 4/2020

Login to get access

Excerpt

A 66-year-old man was admitted to the emergency department of a district general hospital with a 2-day history of asthenia, fever and mild chest discomfort. His past medical history was unremarkable. Blood pressure was 105/66 mmHg with a heart rate of 95 bpm and oxygen saturation of 98% in ambient air. Physical examination revealed no signs of pulmonary or peripheral congestion with normal peripheral perfusion. Abdomen and cardiac evaluations were within limits. Inflammatory markers (CRP 85 mg/dL) and cardiac troponin I (112.1 pg/mL) were elevated. Transthoracic echocardiography (TTE) showed thickened hyperreflective interventricular septum, normal biventricular function and mild pericardial effusion. …
Literature
1.
Caforio AL, Pankuweit S, Arbustini E (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648CrossRef
2.
Adler Y, Charron P, Imazio M et al (2015) ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur Heart J 36(42):2921–2964CrossRef
3.
Ammirati E, Cipriani M, Lilliu M et al (2017) Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 136:529–545CrossRef
4.
Monsieurs KG, Nolan JP, Bossaert LL, ERC Guidelines 2015 Writing Group et al (2015) European Resuscitation Council guidelines for resuscitation 2015. Resuscitation 95:1–80CrossRef
5.
6.
Thiele HE, Ohman M, Desch S, Eitel I, De Waha S (2015) Management of cardiogenic shock. Eur Heart J 36(20):1223–1230CrossRef
7.
Link A, Poss J, Rbahet R et al (2013) Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J 34(22):1651–1662CrossRef
8.
Romagnoli S, Franchi F, Ricci Z, Scolletta S, Payen D (2017) The pressure recording analytical method (PRAM): technical concepts and literature review. J Cardiothorac Vasc Anesth 31(4):1460–1470CrossRef
9.
Van Herck JL, Claeys MJ, De Paep R, Van Herck PL, Vrints CJ, Jorens PG (2015) Management of cardiogenic shock complicating acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 4(3):278–297CrossRef
10.
Lorusso R, Centofanti P, Gelsomino S et al (2016) Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg 101(3):919–926CrossRef
11.
Mirabel M, Luyt C-E, Leprinc P et al (2011) Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 39(5):1029–1035CrossRef
12.
Asaumi Y, Yasuda S, Morii I et al (2005) Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 26:2185–2192CrossRef
13.
Rao P, Khalpey Z, Smith R, Burkhoff Kociol RD (2018) Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail 11(9):e004905CrossRef
14.
Siskin M, Rao S, Rapkiewicz A, Bangalore S, Garshick M (2017) A case of cardiogenic shock secondary to complement-mediated myopericarditis from influenza B infection. Can J Cardiol 33(10):1335CrossRef
15.
Taremi M, Amoroso A, Nace HL, Gilliam BL (2013) Influenza B-induced refractory cardiogenic shock: a case report. BMC Infect Dis 13:452CrossRef
16.
Morimoto S, Kato S, Hiramitsu S et al (2003) Narrowing of the left ventricular cavity associated with transient ventricular wall thickening reduces stroke volume in patients with acute myocarditis. Circ J 67(6):490–494CrossRef
17.
Gräni C, Eichhorn C, Bière L et al (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 70(16):1964–1976CrossRef
18.
Naderi ASA, Palmer BF (2006) Rhabdomyolysis and acute renal failure associated with influenza virus type B infection. Am J Med Sci 332(2):88–89CrossRef
Metadata
Title
Why can flu be so deadly? An unusual case of cardiogenic shock
Authors
Michele Ciabatti
Elisa Vignini
Alessio Mattesini
Carlo Di Mario
Serafina Valente
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 4/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02094-4

Other articles of this Issue 4/2020

Internal and Emergency Medicine 4/2020 Go to the issue

IM - ORIGINAL

Comorbidity does not mean clinical complexity: evidence from the RePoSI register

CE-Research Letter to the Editor

Residual congestion and long-term prognosis in acutely decompensated heart failure patients

IM - COMMENTARY

Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia

Correction

Correction to: Incidence of hyperkalemia in the emergency department: a 10-year retrospective study

IM - COMMENTARY

Septic arthritis in the antimicrobial stewardship era

IM - COMMENTARY

What clinical and health psychology tell to internists and emergency physicians about harm reduction, addiction and asthma?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits